A patient on statin therapy should be monitored for anticipated therapeutic response and potential adverse effects. Monitoring of LDL-C should be used only to assess response to therapy and adherence. It is not an appropriate measure of performance.
To read more or access our algorithms and calculators, please log in or register.
